The global Preclinical Imaging Market consists of various imaging modalities used for in-vivo imaging in small animals for research purposes in biological and preclinical studies. Preclinical imaging allows researchers to non-invasively visualize and quantify biological processes at the molecular, cellular and anatomical level over time, in order to understand disease progression and evaluate the effectiveness of novel drug candidates or devices. Key preclinical imaging modalities include optical imaging, nuclear imaging, MRI, ultrasound, CT, and photoacoustic imaging.
The need for Preclinical Imaging Market Demand has increased significantly owing to the growing research activities in drug discovery and development processes by pharmaceutical companies. Optical imaging dominates the market due to low cost and high-throughput capabilities for screening and studying molecular biological processes in living subjects.
The Global Preclinical Imaging Market is estimated to be valued at US$ 4.25 BN in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global Preclinical Imaging Market are Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm), Inc., Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, and Molecubes. Bruker Corporation holds a dominant share owing to its comprehensive portfolio of preclinical imaging solutions. The key opportunities in the market include the development of multimodal imaging systems integrating two or more modalities to provide complementary anatomical and functional information. Furthermore, growing R&D expenditures in emerging markets such as Asia Pacific is fueling the demand for preclinical imaging solutions and driving global expansion efforts of major players.
Key players are also focusing on new product innovation and launches to expand their product portfolio and cater to the increasing need for high-resolution small animal imaging. For instance, MR solutions launched its 7 tesla small animal MRI system with advanced technology to offer high resolution structural and functional information. The growing pharma industry in developing nations of Asia-Pacific and Latin America will continue to drive global expansion of key players looking to tap into new revenue streams in these regions.
Market drivers: The rising investment by governments and private organizations in preclinical research and drug development is a major factor propelling market growth. In addition, increasing global burden of chronic and lifestyle diseases has accelerated pharmaceutical R&D activities, thus augmenting demand for preclinical studies and associated imaging modalities.
Market Restrains: However, the high cost of preclinical imaging systems and maintenance is a major restraint for small research laboratories and academia in developing nations. Stringent regulatory frameworks and lengthy approval processes for new preclinical imaging systems also hampers market growth. Additionally, lack of specialist workforce to operate complex preclinical imaging equipment poses operational challenges.
Segment Analysis
The global Preclinical Imaging Market can be segmented based on reagent, technology, application, and end user. Among the technologies, optical imaging is the dominating sub-segment currently due to its non-invasive nature and reduced cost compared to other technologies. It provides high resolution images at cellular and molecular levels, which makes it a preferred choice for various preclinical applications.
Regional Analysis
North America is the fastest growing and dominating region in the global Preclinical Imaging Market currently. This is majorly due to rising R&D investments in drug development and availability of supportive reimbursement policies in the region. Asia Pacific is also expected to witness significant growth during the forecast period owing to increasing government funding for research, growing diagnostics industry, and rising awareness about the benefits of early disease diagnosis.
Get More Insights on Preclinical Imaging Market
Comments
0 comment